To verify that R-909 infection occurs through the interaction of the chimeric gB (gBHER2) with HER2, we verified whether gBHER2 binds HER2, and whether R-909 infection was inhibited by trastuzumab, the MAb to HER2 from which the scFv was derived [50]. Here, ERBB2 is linked to infection.